基本信息
文件名称:VEGFR-2-IN-66-生命科学试剂-MCE.pdf
文件大小:464.3 KB
总页数:1 页
更新时间:2025-05-22
总字数:约1.98千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

VEGFR-2-IN-66

Cat.No.:HY-173232

分?式:C??H??N?O?

分?量:422.44

作?靶点:VEGFR;Apoptosis

作?通路:ProteinTyrosineKinase/RTK;Apoptosis

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性VEGFR-2-IN-66(Compound6)是?种具有?服活性的VEGFR-2抑制剂,IC50值为0.509μM,对MCF-7细胞

增殖抑制IC50值为7.48μM。VEGFR-2-IN-66通过阻滞细胞周期、诱导凋亡(Apoptosis)、调节基因表达来发

挥抗癌活性,可?于乳腺癌领域的研究[1]。

IC50TargetVEGFR2

509nM(IC50)

REFERENCES

[1].MabroukRR,etal.NoveltriazoloquinazolinederivativesasVEGFRinhibitors:synthesis,cytotoxicevaluationandinsilicostudies.

FutureMedChem.2025Mar;17(5):529-541.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1MasterofBioactiveMolecules—您?边的抑制剂?师